FAQs & How to use this site
Home | About Us | Contact Us
The Front Line
The Front Line: Charles D. Blanke, MD, SWOG Chair
ABOUT

PREVIOUS POSTS September 2017

August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 October 2016 September 2016 August 2016 July 2016 JUNE 2016 MAY 2016 APRIL 2016 MARCH 2016 FEB 2016 JAN 2016 DEC 2015 NOV 2015 OCT 2015 SEP 2015 AUG 2015 JUL 2015 JUN 2015 MAY 2015 APR 2015 MAR 2015 FEB 2015 JAN 2015 DEC 2014 NOV 2014 OCT 2014 SEP 2014 AUG 2014 JUL 2014 JUN 2014 MAY 2014 APR 2014 MAR 2014 FEB 2014 JAN 2014 DEC 2013 NOV 2013 OCT 2013 SEP 2013 AUG 2013 JUL 2013

ASCO and the NCTN: Leading cancer research. Together.

Jan 10, 2014 - Running the risk that the braying you hear is me tooting my own horn, I do want to say that I am pleased and honored to have recently been elected to the Board of Directors of the American Society of Clinical Oncology, or ASCO. A friend to me and to SWOG, Dr. Walter Curran, past chair of the Radiation Therapy Oncology Group (RTOG) and one of the founding principal investigators of the consolidated NRG Oncology cooperative group, also was elected. I truly believe the presence of two cooperative group chairs on the ASCO Board -- especially two who represent different disciplines -- can provide unprecedented opportunities to develop synergies between ASCO and the NCI's emerging National Clinical Trials Network (NCTN).

Certainly ASCO and SWOG share a common overarching mission, with the intersection coming into clearest focus in one well turned line from ASCO's vision statement: "Information we learn from every patient will be used to accelerate progress against cancer." We also share values and challenges. Patients and patient-centric activities are paramount in both our organizations. And both organizations plan to move forward doing a better job of engaging our constituencies (physician scientists and patients) and joining other, non-medical sectors in realizing the value of modernizing our information systems, with particular attention paid to effectively measuring what we are accomplishing and to help point us toward what we should be doing.

My model in balancing these NCTN and ASCO roles is, of course, Dr. Richard Schilsky, past president and current Chief Medical Officer of ASCO, and Chair of CALGB for many years. Dr. Schilsky has championed the cooperative group enterprise in many venues and under many hats, including his various ASCO roles, to the benefit of both groups. While he is uniquely competent, and I am certainly no Rich Schilsky, I do hope to learn from how he conducted himself in his dual roles, again, like Dr. Schilsky, bringing something useful back from each organization to each organization. It should be an interesting next four years!

 

 
     
SWOG Logo Disclaimer | Copyright ©2000-2017 SWOG. All rights reserved.
Design by nuMedia Group Inc. | Hosting by WorldPost Technologies, Inc.
SWOG is FISMA CertifiedSWOG is FISMA Certified